Arkolith/Insider Trading/STOK/Form 4

Kaye Edward M. MD

DirectorStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$433K
Net Open-Market Flow
-$433K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2025Sell(S)8K$32.52$269K50K
Dec 8, 2025Sell(S)4K$31.44$120K59K
Dec 8, 2025Sell(S)1K$33.10$44K49K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001522780-25-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML